HJ Science Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Revenue	12.98	1.8
Other Revenue	0.09	0.77
Revenue	13.07	2.57
Revenue Growth (YoY)	407.77%	-
Gross Profit	13.07	2.57
Selling, General & Admin	28.29	12.64
Research & Development	110.18	74.97
Operating Expenses	138.47	87.61
Operating Income	-125.4	-85.03
Interest Expense	-0.13	-0.05
Interest & Investment Income	0.09	2.08
Earnings From Equity Investments	-0.16	-0.24
Other Non Operating Income (Expenses)	-16.03	-124.73
EBT Excluding Unusual Items	-141.63	-207.97
Gain (Loss) on Sale of Investments	6.54	5.65
Gain (Loss) on Sale of Assets	0	-
Pretax Income	-135.08	-202.32
Income Tax Expense	0	-
Net Income	-135.08	-202.32
Net Income to Common	-135.08	-202.32
Shares Outstanding (Basic)	59	40
Shares Outstanding (Diluted)	59	40
Shares Change (YoY)	50.01%	-
EPS (Basic)	-2.28	-5.12
EPS (Diluted)	-2.28	-5.12
Free Cash Flow	-90.95	-79.67
Free Cash Flow Per Share	-1.53	-2.02
Gross Margin	100.00%	100.00%
Operating Margin	-959.44%	-3303.57%
Profit Margin	-1033.54%	-7860.02%
Free Cash Flow Margin	-695.85%	-3095.26%
EBITDA	-123.46	-82.77
D&A For EBITDA	1.94	2.26
EBIT	-125.4	-85.03